| Literature DB >> 27482352 |
Lubna Hamid Tahtamouni1, Rema Ahmad Al-Khateeb1, Reem Nasser Abdellatif1, Zainab Ali Al-Mazaydeh1, Salem Refaat Yasin1, Samer Al-Gharabli2, Ali Zuhair Elkarmi1.
Abstract
Taraxacum officinale has been used in Jordan folk medicine to treat male infertility. A recent study has proved a contradictory effect of the whole plant aqueous extract. The aim of the current study was to determine if the leaves of T. officinale have similar anti-fertility activities, and whether this effect is mediated through the regulation of spermatogonial stem cells (SSCs). Fifty adult male rats were divided into five groups. Two groups were gavaged with 1/10 of LD50 of T. officinale whole plant (1.06 g kg(-1) body weight) or leaves (2.30 g kg(-1) body weight) aqueous extract; while two groups were gavaged with 1/20 of LD50 of T. officinale whole plant (2.13 g kg(-1)) or leaves (4.60 g kg(-1)) extract. The control group received distilled water. Oral administration of T. officinale (whole plant and leaves aqueous extract) caused a significant decrease in testis and seminal vesicle weight, a reduction in serum testosterone concentration, impaired sperm parameters, and a decrease in pregnancy parameters. Testicular histology of treated rats showed structural changes such as hypoplasia of germ cells, reduction in the thickness of germinal epithelium, arrest of spermatogenesis at spermatid stage (late maturation arrest) and reduction in the number of Leydig cells. Gene expression levels of two SSCs markers (GFRα1 and CSF1) responsible for self-renewal were relatively counter-balanced. In conclusion, T. officinale whole plant and leaves aqueous extracts changed the gene expression of two SSCs markers leading to the imbalance between spermatogonia self-renewal and differentiation causing late maturation arrest.Entities:
Keywords: Dandelion; Maturation arrest; Rat; Renewal; Spermatogenesis
Year: 2016 PMID: 27482352 PMCID: PMC4959335
Source DB: PubMed Journal: Vet Res Forum ISSN: 2008-8140 Impact factor: 1.054
Fig. 1) HPLC-MS chromatogram of T. officinale leaves aqueous extract; B) HPLC-MS chromatogram of T. officinale whole plant aqueous extract
Body weight gain and organ weight (g) in control and treated groups. Values are expressed as mean ± SD, n = 10 in each group.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| 80.20 ± 13.70 | 1.80 ± 0.20 | 1.20 ± 0.30 | 10.70 ± 0.40 | 1.10 ± 0.20 |
|
| 95.30 ± 17.20 | 1.70 ± 0.20 | 1.00 ± 0.10a2 | 9.90 ± 1.00 | 1.00 ± 0.20 |
|
| 82.60 ± 21.10 | 1.40 ± 0.30ab | 0.90 ± 0.10a2 | 10.20 ± 1.30 | 0.90 ± 0.20 |
|
| 93.00 ± 33.60 | 1.50 ± 0.10ab | 0.80 ± 0.10a2 | 9.70 ± 1.50 | 0.90 ± 0.10 |
|
| 84.90 ± 33.30 | 1.40 ± 0.10ab | 0.70 ± 0.20a3 | 9.50 ± 0.90 | 0.90 ± 0.10 |
LDWP: Low dose-receiving whole plant; HDWP: High dose-receiving whole plant; LDL: Low dose-receiving leaves; HDL: High dose-receiving leaves. a: p < 0.05; a2: p < 0.01; a3: p < 0.001 compared to control, b: p < 0.05 compared to LDWP.
Effect of Taraxacum officinale whole plant or leaves aqueous extract on testosterone concentration and sperm parameters. Values are expressed as mean ± SD, n=10 in each group
|
|
|
|
|
|
|---|---|---|---|---|
|
| 4.20 ± 0.40 | 85.20 ± 9.20 | 67.60 ± 8.70 | 3.90 ± 1.10 |
|
| 1.90 ± 0.20 | 45.30 ± 7.10 | 32.40 ± 5.10 | 21.20 ± 4.90 |
|
| 1.80 ± 0.30 | 42.90 ± 5.70 | 29.10 ± 9.70 | 35.70 ± 7.20 |
|
| 1.80 ± 0.40 | 37.10 ± 5.20 | 24.80 ± 3.90 | 41.90 ± 13.60 |
|
| 1.50 ± 0.20 | 34.10 ± 5.00 | 25.50 ± 3.40 | 46.90 ± 6.80 |
LDWP: Low dose-receiving whole plant; HDWP: High dose-receiving whole plant; LDL: Low dose-receiving leaves; HDL: High dose-receiving leaves.
: p 0.01;
: p 0.001 compared to control,
: p 0.05;
: p 0.01;
: p 0.001 compared to LDWP,
: p 0.05;
: p 0.01;
: p 0.001 compared to HDWP,
: p 0.05;
: p 0.001 compared to LDL,
: p 0.05 ;
: p < 0.01,
: p < 0.001 compared to HDL.
Fig. 2Effect of T. officinale treatment on rat sperm morphology and chromatin integrity. A) Normal rat sperm showing the hooked head and tail. B) Coiled-tail sperm (dashed arrow) and tailless sperm (arrow). C) Sperm agglutination. D) Tailless sperm (red arrow) and coiled-tail sperm (dashed arrow). E) Evaluation of chromatin integrity by acridine orange staining. All sperms showed green fluorescence indicating integrated chromatin. F) Representative agarose gel electrophoresis analysis of sperm DNA of control and treated rats. Lane 1: 1 kb DNA molecular weight marker; Lane 2: Control; Lane 3: LDWP; Lane 4: HDWP; Lane 5: LDL; Lane 6: HDL
Fig. 3Treatment of male rats with Taraxucum officinale whole plant or leaves aqueous extract causes disruption in spermato-genesis. A, B) Testicular cross sections from control rat showing seminiferous tubules consisting of lumen (L) and germinal epithelium (GE) and interstitial tissue including Leydig cells (arrow) and myoid cells (arrow head). The seminiferous tubule shows organized germinal epithelium with typical spermatogenic cells: spermatogonia (SG); spermatocytes (SC); spermatids (SD); and sperms (S). C) Cross section of seminiferous tubules of LDWP-receiving group showing increased spaces between seminiferous tubules, interstitial tissue hypoplasia, and spermatogenesis late maturation arrest (dashed arrow). D) Cross section of semini-ferous tubules of HDWP-receiving group showing germinal epithelium disorganization and late maturation arrest (dashed arrow). E) Cross section of seminiferous tubule of LDL-receiving group showing late maturation arrest (dashed arrow) and a reduction in germinal epithelium thickness. F) Cross section of seminiferous tubule of HDL-receiving group showing late maturation arrest (dashed arrow) and hypoplasia of germ cells and interstitial tissue (H & E, Scale bar = 50 μm for all panels
Effect of T. officinale treatment on testicular histology of control and treated groups. Values are expressed as mean ± SD, n = 10 in each group
|
|
|
|
|
|
|---|---|---|---|---|
|
| 2510.60 ± 11.90 | 70.40 ± 3.10 | 31.10 ± 2.20 | 8.10 ± 1.60 |
|
| 188.10 ± 25.10 | 48.30 ± 4.90 | 41.90 ± 4.10 | 6.20 ± 1.80 |
|
| 127.50 ± 12.10 | 28.20 ± 2.80 | 46.20 ± 4.80 | 5.20 ± 1.20 |
|
| 159.60 ± 13.20 | 34.90 ± 9.910 | 54.20 ± 3.90 | 4.50 ± 1.60 |
|
| 136.50 ± 17.90 | 26.00 ± 1.300 | 58.30 ± 5.30 | 3.70 ± 1.50 |
LDWP: Low dose-receiving whole plant; HDWP: High dose-receiving whole plant; LDL: Low dose-receiving leaves; HDL: High dose-receiving leaves.
: p 0.05;
: p 0.01;
: p 0.001 compared to control,
p 0.05;
p 0.01;
: p 0.001 compared to LDWP,
: p 0.05 compared to HDWP,
: p 0.05 compared to LDL,
: p < 0.01 compared to HDL.
Fig. 4RT-PCR analysis of mRNA level of spermatogonial stem cells markers in control and treated groups. A) Representative agarose gel electrophoresis of RT-PCR products of control and treated rats. Lane 1: Control; lane 2: LDWP; lane 3: HDWP; lane 4: LDL; lane 5: HDL. B) Relative quantity of PLZF, GFRα1, and CSF1 mRNA in treated groups in comparison to the control group, values were normalized to β-actin. Values are expressed as mean ± SD, n=10 in each experiment, three independent experiments. a: p 0.05; a2: p 0.01; a3: p 0.001 versus control, b2: p 0.01 versus LDWP, c2: p 0.01 versus HDWP, d: p 0.05; d2: p 0.01 versus LDL, e: p 0.05 ; e2: p < 0.01 versus HDL
Fig. 5Taraxacum officinale treatment leads to changes in protein levels of spermatogonial stem cells. A) Representative Western blot of testicular lysates of control and treated rats blotted for spermatogonial stem cell markers CSF1; PLZF; and GFR 1. β-actin was used as a loading marker. Lane 1: Control; lane 2: LDWP; lane 3: HDWP; lane 4: LDL; lane 5: HDL. The experiment was repeated three times and the corresponding quantification is shown in (B). B) Quantification of CSF1, PLZF, and GFRα1 protein levels (normalized to actin) in control and treated rats. a: p 0.05; a2: p 0.01; a3: p 0.001 compared to control, b: p 0.05; b2: p 0.01; b3: p 0.001 compared to LDWP, c: p 0.05; c2: p 0.01 compared to HDWP, d: p 0.05; d3: p 0.001 compared to LDL, e: p 0.05 ; e3: p < 0.001 compared to HDL